openPR Logo
Press release

Neuromodulation Market is Expected to Reach US$ 11 Billion by 2022

07-03-2017 09:30 AM CET | Health & Medicine

Press release from: Market Research Engine Reports - MRE

The Global Neuromodulation Market is segmented on the lines of its technology, application and biomaterial. Technology segmentation is further classified into internal neuromodulation and external neuromodulation. Based on internal neuromodulation segmentation it covers deep brain stimulation, spinal cord stimulation, vagus nerve stimulation, sacral nerve stimulation and other neuromodulation technologies. External neuromodulation is classified into transcranial magnetic stimulation and transcutaneous electrical nerve stimulation. Based on application segmentation it covers chronic pain management, tremor, failed back syndrome, epilepsy, depression, urinary and fecal incontinence, dystonia, obsessive compulsive, disorder, gastroparesis, migraine, parkinson’s disease and other applications. Under biomaterial segmentation it covers polymeric biomaterials, metallic biomaterials and ceramic biomaterials.

Browse Full Report @:

How Big is the Global Neuromodulation Market?

The Global Neuromodulation Market is expected to exceed more than US$ 11 Billion by 2022 and will grow at a CAGR of more than 11% in the given forecast period.

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Medtronic plc, St. Jude Medical, Inc., LivaNova PLC, Boston Scientific Corporation, Aleva Neurotherapeutics SA, BioControl Medical, Bioness Inc., EnteroMedics Inc., Nevro Corporation and NeuroPace Inc. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.

The Global Neuromodulation market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geography market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.

Table of Contents

2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Global Neuromodulation Market, By Technology
7 Global Neuromodulation Market, By Application
8 Neuromodulation Market, By Region
9 Competitive Landscape
10 Company Profiles
10.1 Introduction
10.2 Medtronic, Inc.
10.3 Boston Scientific Corporation
10.4 ST. Jude Medical, Inc.
10.5 Cyberonics, Inc.
10.6 Nevro Corporation
10.7 Neurosigma, Inc.
10.8 Neuropace, Inc.
10.9 Biocontrol Medical
10.10 Synapse Biomedical, Inc.
10.11 Neuronetics, Inc.

About MarketResearchEngine

Market Research Engine is a global market research and consulting organization. We provide market intelligence in emerging, niche technologies and markets. Our market analysis powered by rigorous methodology and quality metrics provide information and forecasts across emerging markets, emerging technologies and emerging business models. Our deep focus on industry verticals and country reports help our clients to identify opportunities and develop business strategies.

Media Contact

Contact Person: John Bay
Phone: +1-855-984-1862
Country: United States

Address: 3422 SW 15 Street, Suite #8942, Deerfield Beach, FL 33442, United States

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Neuromodulation Market is Expected to Reach US$ 11 Billion by 2022 here

News-ID: 604922 • Views: 166

More Releases from Market Research Engine Reports - MRE

Medical Image Analysis Software Market is Expected to Exceed US$ 3.3 Billion by …
The global medical image analysis software market by software type is segmented as integrated software and standalone software. According to its image types the market is further segmented in to 2D, 3D and 4D imaging. The market is further segmented according to its modality such as tomography, ultrasound imaging, radiography imaging and combined modalities. The application segment consists of orthopedic, dental, neurology, cardiology, oncology, obstetrics and gynecology, mammography and urology
Pharmacovigilance Market will Rise at a CAGR of 13% During the Forecast, by 2020
The global pharmacovigilance market according to clinical trial phase is segmented aspre-clinical, Phase I, Phase II, Phase IIIandPhase IV. The type of service provider segment consists of In-House and contract outsourcing. The market segments in terms of geographical regions include North America, Europe, Asia-Pacific and Rest of the World(ROW). Browse Full Report @: How Big is the Global Pharmacovigilance Market? Global pharmacovigilance market was valued USD 2.5 billion in 2014. The revenue
Biomarkers Market is Expected Exceed US$ 60.0 Billion by 2023
The main driving factors for biomarkers market are increase in number of low cost for conducting clinical trials in developing countries. Rising healthcare expenditure and R&D funding are the major macro drivers of the market. The use of biomarkers in diagnostic process is increasing rapidly due to its more accurate results. The biomarkers also have some restraints such as it contain technical issues related to sample and storage. The testing
Automated External Defibrillator Market is Expected to Reach US$ 15 Billion by 2 …
The Global Automated External Defibrillator Market is segmented on the lines of its type, end user and regional. Based on type segmentation it covers semi automated external defibrillator and fully automated external defibrillator. Under end user segmentation it covers home based, hospitals and pre hospitals. Browse Full Report @: How Big is the Global Automated External Defibrillator? The Global Automated External Defibrillator Market is expected to exceed more than US$ 15

All 5 Releases

More Releases for Neuromodulation

Neuromodulation Market Overview and Industry Outlook 2020
Global Neuromodulation Market research report published by market insight reports explores the current outlook in global and key regions from the perspective of Major Players, Countries, Product types and end industries. This report analyzes top players in the global market, and divides the Market into several parameters. This Neuromodulation Market research report identifies the competitive landscape of industries to understand the competition at International level. This report study describes the projected
Neuromodulation Devices Market Analysis and Forecast Study for 2017-2027
Neuromodulation is technology that is used for the alteration or modulation of the nerve activity by using chemical agents or electrical stimulation to the specific neurological sites in the body. Most of the neuromodulation devices work through electrical stimulation.Neuromodulation devices are used by the application of electrodes to the brain, peripheral nerves or the spinal cord. The electrode leads in neuromodulation devices are connected through an extension cable to a
Sacral Neuromodulation Systems Market Outlook to 2025
Sacral neuromodulation, also known as sacral nerve stimulation, is a type of electrical stimulation. Sacral neuromodulation system is an implanted system that can help improve the functioning of the bladder by sending electrical signals to the nerves, which control bladder activities. According to a study on neuromodulation devices and therapies, neuromodulation is a safe, effective, and long term treatment for chronic pain and movement disorders. Neuromodulation technology is gaining momentum
Internal Neuromodulation Devices Market : Global Markets & Advanced Technologies
Internal neuromodulation devices directly act upon nerves. It is the technology known for alteration of nerve activity directly to a target area by sending electrical or pharmaceutical agents directly to a target area. The neuromodulation devices can treat nearly every disease considering every area of body. The diseases or symptoms from headache to spinal cord damage to tremor and many others. Neuromodulation technology is significantly improving in biotechnology with its
Global Neuromodulation Market Research Report 2016 - MRH
This report of MRH studies Neuromodulation in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacture. Request Free Sample Report: Area Covering Medtronic, Inc. (U.S.) Boston Scientific Corporation (U.S.) St. Jude Medical, Inc. (U.S.) Synapse Biomedical, Inc. (U.S.) Nevro Corporation (U.S.) Neurosigma, Inc. (U.S.) Neuropace, Inc. (U.S.). Neuronetics, Inc. (U.S.) Cyberonics, Inc. (U.S.) BioControl Medical (Israel) Market Segment by Regions,
Europe Neuromodulation Devices And Implantable Infusion Pumps Market Report 2017
MarketResearchReports.Biz presents this most up-to-date research on "Europe Neuromodulation Devices And Implantable Infusion Pumps Market Report 2017" Description This report studies sales (consumption) of Neuromodulation Devices And Implantable Infusion Pumps in Europe market, especially in GermaAbout us is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are